Summary & Overview
HCPCS G8944: AJCC Melanoma Stage 0 through IIC
HCPCS Level II code G8944 designates AJCC melanoma cancer staging for stage 0 through IIC disease. This code captures clinical staging activity for early-stage melanoma and is relevant for tracking care pathways, documenting disease extent, and supporting appropriate clinical decision-making. Nationally, accurate use of this code supports consistent staging documentation across oncology and dermatology practices and informs quality reporting and care coordination for patients with early melanoma.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical purpose, typical sites of service (oncology and dermatology outpatient settings), and the service type (melanoma staging assessment). The publication provides benchmarks where available, summaries of relevant policy or billing guidance, and clinical context for proper use of the code. Data not available in the input will be noted explicitly where applicable.
This summary is intended for billing managers, clinicians in oncology and dermatology, and policy analysts seeking a concise reference on G8944 and its role in documenting AJCC melanoma staging for stages 0 through IIC.
Billing Code Overview
HCPCS Level II code G8944 describes AJCC melanoma cancer stage 0 through IIC melanoma. The code represents clinical staging activity related to early-stage melanoma classification under the American Joint Committee on Cancer (AJCC) criteria. The service type is staging assessment for melanoma, and the typical site of service is oncology clinics, dermatology clinics, and outpatient surgical or procedural settings where melanoma staging and classification are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult recently diagnosed with early-stage cutaneous melanoma staged AJCC 0 through IIC following histologic confirmation via excisional biopsy. The patient presents to an outpatient dermatology or surgical oncology clinic for staging assessment, treatment planning, and documentation of stage for registry/quality reporting. Workflow includes review of the pathology report (tumor thickness, ulceration, mitotic rate), focused skin and regional lymph node exam, discussion of treatment options (wide local excision, sentinel lymph node biopsy for appropriate tumors), ordering of baseline imaging when indicated, and formal AJCC staging assignment documented in the medical record. The service represented by G8944 is used to report the AJCC melanoma stage (0 through IIC) for clinical tracking, billing, and registry submission. Typical sites of service are outpatient dermatology clinics, surgical oncology clinics, hospital outpatient departments, and cancer centers. Typical patient scenario: a 58-year-old with a 1.2 mm non-ulcerated superficial spreading melanoma on the upper back after excisional biopsy, seen for staging and surgical planning where the clinician documents AJCC stage IB (or within the specified range up to IIC) and records stage-specific details in the chart for treatment and registry reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |